RU2015113595A - Комбинация хромофоров для биофотонных применений - Google Patents
Комбинация хромофоров для биофотонных применений Download PDFInfo
- Publication number
- RU2015113595A RU2015113595A RU2015113595A RU2015113595A RU2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- therapy
- xanthene dye
- xanthene
- biophoton
- Prior art date
Links
- 239000001018 xanthene dye Substances 0.000 claims abstract 47
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 42
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims abstract 12
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 claims abstract 12
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims abstract 12
- 230000000699 topical effect Effects 0.000 claims abstract 11
- 238000000862 absorption spectrum Methods 0.000 claims abstract 10
- 238000000295 emission spectrum Methods 0.000 claims abstract 4
- 230000004913 activation Effects 0.000 claims abstract 2
- 238000001429 visible spectrum Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 11
- 210000001519 tissue Anatomy 0.000 claims 11
- 210000003491 skin Anatomy 0.000 claims 6
- 208000017520 skin disease Diseases 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000003213 activating effect Effects 0.000 claims 3
- 230000001678 irradiating effect Effects 0.000 claims 3
- 230000003716 rejuvenation Effects 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 230000031700 light absorption Effects 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims 1
- 101710155833 C-C motif chemokine 8 Proteins 0.000 claims 1
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 101100441523 Homo sapiens CXCL5 gene Proteins 0.000 claims 1
- 101000852968 Homo sapiens Interleukin-1 receptor-like 1 Proteins 0.000 claims 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 claims 1
- 101000990908 Homo sapiens Neutrophil collagenase Proteins 0.000 claims 1
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 claims 1
- 101000577874 Homo sapiens Stromelysin-2 Proteins 0.000 claims 1
- 101000585365 Homo sapiens Sulfotransferase 2A1 Proteins 0.000 claims 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims 1
- 102100030411 Neutrophil collagenase Human genes 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 102100030416 Stromelysin-1 Human genes 0.000 claims 1
- 102100028848 Stromelysin-2 Human genes 0.000 claims 1
- 102100029867 Sulfotransferase 2A1 Human genes 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 230000020169 heat generation Effects 0.000 claims 1
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 230000017423 tissue regeneration Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701502P | 2012-09-14 | 2012-09-14 | |
| US201261701510P | 2012-09-14 | 2012-09-14 | |
| US201261701513P | 2012-09-14 | 2012-09-14 | |
| US61/701,502 | 2012-09-14 | ||
| US61/701,513 | 2012-09-14 | ||
| US61/701,510 | 2012-09-14 | ||
| US201361766611P | 2013-02-19 | 2013-02-19 | |
| US61/766,611 | 2013-02-19 | ||
| US13/830,488 | 2013-03-14 | ||
| US13/830,488 US20130281913A1 (en) | 2012-04-20 | 2013-03-14 | Biophotonic compositions and methods for providing biophotonic treatment |
| GB1307157.6 | 2013-04-19 | ||
| CAPCT/CA2013/000395 | 2013-04-19 | ||
| GB1307157.6A GB2499921B (en) | 2012-04-20 | 2013-04-19 | Biophotonic compositions, kits and methods |
| PCT/CA2013/000395 WO2013155620A1 (en) | 2012-04-20 | 2013-04-19 | Biophotonic compositions, kits and methods |
| US201361873791P | 2013-09-04 | 2013-09-04 | |
| US61/873,791 | 2013-09-04 | ||
| PCT/CA2013/000786 WO2014040176A1 (en) | 2012-09-14 | 2013-09-13 | Chromophore combinations for biophotonic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015113595A true RU2015113595A (ru) | 2016-11-10 |
Family
ID=50277449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015113595A RU2015113595A (ru) | 2012-09-14 | 2013-09-13 | Комбинация хромофоров для биофотонных применений |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190133908A1 (enExample) |
| EP (3) | EP2895194A4 (enExample) |
| JP (3) | JP2015528472A (enExample) |
| KR (3) | KR20180110240A (enExample) |
| CN (1) | CN104755101B (enExample) |
| AU (1) | AU2013315303B2 (enExample) |
| BR (1) | BR112015005382A2 (enExample) |
| HK (2) | HK1212592A1 (enExample) |
| IL (1) | IL237657A0 (enExample) |
| IN (1) | IN2015DN02938A (enExample) |
| MX (1) | MX367670B (enExample) |
| RU (1) | RU2015113595A (enExample) |
| WO (1) | WO2014040176A1 (enExample) |
| ZA (1) | ZA201501700B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA029534B1 (ru) | 2008-11-07 | 2018-04-30 | Клокс Текнолоджиз Инк. | Комбинация оксиданта и фотоактиватора для заживления ран |
| DK2453922T3 (en) | 2009-07-17 | 2018-01-02 | Klox Tech Inc | ANTIBACTERIAL ORAL COMPOSITION |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| WO2014040176A1 (en) * | 2012-09-14 | 2014-03-20 | Klox Technologies Inc. | Chromophore combinations for biophotonic uses |
| IN2015DN02939A (enExample) * | 2012-09-14 | 2015-09-18 | Klox Technologies Inc | |
| US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| KR20210108505A (ko) | 2013-07-03 | 2021-09-02 | 광동 클록스 바이오메디컬 그룹 씨오., 엘티디 | 상처를 치료하기 위한 발색단과 겔화제를 포함하는 생체광자성 조성물 |
| WO2015149177A1 (en) | 2014-04-01 | 2015-10-08 | Klox Technologies Inc. | Tissue filler compositions and methods of use |
| AU2015271615A1 (en) * | 2014-06-04 | 2016-12-08 | Klox Technologies Inc. | Biophotonic hydrogels |
| US11266685B2 (en) | 2014-06-09 | 2022-03-08 | Klox Technologies Inc. | Silicone-based biophotonic compositions and uses thereof |
| CN106687151A (zh) * | 2014-09-15 | 2017-05-17 | 克洛克斯科技公司 | 发射性聚合物基质 |
| EP3212826B1 (en) * | 2014-10-31 | 2020-10-14 | Klox Technologies Inc. | Photoactivatable fibers and fabric media |
| JP2016172705A (ja) * | 2015-03-17 | 2016-09-29 | 国立大学法人 東京大学 | Ｍｉｎｔ３阻害剤 |
| US10610513B2 (en) * | 2016-01-11 | 2020-04-07 | Klox Technologies Limited | Biophotonic compositions for the treatment of otitis externa |
| WO2017120674A1 (en) | 2016-01-11 | 2017-07-20 | Klox Technologies Limited | Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections |
| EP3402523A4 (en) * | 2016-01-11 | 2019-07-24 | Francesco Bellini | BIOPHOTONIC COMPOSITIONS FOR THE TREATMENT OF PYODERMA |
| WO2017201531A1 (en) * | 2016-05-20 | 2017-11-23 | Howard Hughes Medical Institute | Photoactive fluorophores and methods of in vivo labeling |
| WO2018053646A1 (en) | 2016-09-23 | 2018-03-29 | Klox Technologies Inc. | Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms |
| CA3037397A1 (en) * | 2016-09-23 | 2018-03-29 | Klox Technologies Inc. | Biophotonic compositions and methods for reducing scarring |
| CN110494165A (zh) * | 2017-01-27 | 2019-11-22 | 克洛克斯科技公司 | 使用自生物光子组合物或生物光子系统产生和发射的荧光进行生物过程的光生物调控的方法 |
| US20210170027A1 (en) * | 2017-11-17 | 2021-06-10 | Klox Technologies Limited | Biophotonic compositions, methods and kits for enhancing hair growth |
| AU2018367960A1 (en) * | 2017-11-17 | 2020-06-04 | Klox Technologies Limited | Modulation of biophotonic regimens |
| US10322297B1 (en) * | 2018-08-21 | 2019-06-18 | Lumia Group, LLC | Electrically passive low-level light therapy system and methods incorporating same |
| KR102730110B1 (ko) * | 2018-10-18 | 2024-11-15 | 주식회사 엘지에너지솔루션 | 비수전해액 및 이를 포함하는 리튬 이차전지 |
| DE102022118867A1 (de) * | 2022-07-27 | 2024-02-01 | Thomas Klose | Gerät und Zusammensetzung zur Behandlung einer Wunde, Kartusche für das Gerät, Verfahren zur Herstellung der Zusammensetzung |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320140A (en) * | 1980-10-09 | 1982-03-16 | Sterling Drug Inc. | Synergistic insecticidal compositions |
| US4647578A (en) * | 1983-12-02 | 1987-03-03 | Sterling Drug Inc. | Phototoxic insecticidal compositions and method of use thereof |
| AU732936B2 (en) * | 1997-02-03 | 2001-05-03 | Ciba Specialty Chemicals Holding Inc. | Fluorescent materials and their use |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US6676655B2 (en) * | 1998-11-30 | 2004-01-13 | Light Bioscience L.L.C. | Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
| CN1372467A (zh) * | 1999-08-13 | 2002-10-02 | 福托金公司 | 改进的局部用药物和疾病的光动力学治疗方法 |
| EP1478713A1 (en) * | 2002-02-01 | 2004-11-24 | Ciba SC Holding AG | Fluorescent compositions comprising diketopyrrolopyrroles |
| US20050059731A1 (en) * | 2003-09-16 | 2005-03-17 | Ceramoptec Industries, Inc. | Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| US7344701B2 (en) * | 2004-02-03 | 2008-03-18 | Biosearch Technologies, Inc. | Xanthene dyes |
| CN101340887B (zh) * | 2005-11-09 | 2014-01-29 | 科洛斯科技公司 | 使牙齿增白的组合物及方法 |
| US20100266989A1 (en) * | 2006-11-09 | 2010-10-21 | Klox Technologies Inc. | Teeth whitening compositions and methods |
| EA029534B1 (ru) * | 2008-11-07 | 2018-04-30 | Клокс Текнолоджиз Инк. | Комбинация оксиданта и фотоактиватора для заживления ран |
| DK2453922T3 (en) * | 2009-07-17 | 2018-01-02 | Klox Tech Inc | ANTIBACTERIAL ORAL COMPOSITION |
| GB201200490D0 (en) * | 2012-01-12 | 2012-02-22 | Univ Bath | Wound dressing |
| WO2014040176A1 (en) * | 2012-09-14 | 2014-03-20 | Klox Technologies Inc. | Chromophore combinations for biophotonic uses |
| US20130281913A1 (en) * | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| US11116841B2 (en) * | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
-
2013
- 2013-09-13 WO PCT/CA2013/000786 patent/WO2014040176A1/en not_active Ceased
- 2013-09-13 KR KR1020187028357A patent/KR20180110240A/ko not_active Ceased
- 2013-09-13 IN IN2938DEN2015 patent/IN2015DN02938A/en unknown
- 2013-09-13 AU AU2013315303A patent/AU2013315303B2/en not_active Ceased
- 2013-09-13 KR KR1020157006411A patent/KR20150068358A/ko not_active Withdrawn
- 2013-09-13 KR KR1020217017420A patent/KR20210072827A/ko not_active Ceased
- 2013-09-13 CN CN201380047508.0A patent/CN104755101B/zh active Active
- 2013-09-13 EP EP13836318.9A patent/EP2895194A4/en not_active Withdrawn
- 2013-09-13 HK HK16100462.1A patent/HK1212592A1/zh unknown
- 2013-09-13 MX MX2015003361A patent/MX367670B/es active IP Right Grant
- 2013-09-13 HK HK15109532.9A patent/HK1208807A1/xx unknown
- 2013-09-13 BR BR112015005382A patent/BR112015005382A2/pt not_active Application Discontinuation
- 2013-09-13 JP JP2015531408A patent/JP2015528472A/ja active Pending
- 2013-09-13 EP EP17196260.8A patent/EP3329938B1/en active Active
- 2013-09-13 RU RU2015113595A patent/RU2015113595A/ru not_active Application Discontinuation
- 2013-09-13 EP EP16184973.2A patent/EP3153177A1/en not_active Withdrawn
-
2015
- 2015-03-10 IL IL237657A patent/IL237657A0/en unknown
- 2015-03-12 ZA ZA2015/01700A patent/ZA201501700B/en unknown
-
2017
- 2017-12-13 JP JP2017238941A patent/JP2018076343A/ja active Pending
-
2018
- 2018-12-19 US US16/225,672 patent/US20190133908A1/en not_active Abandoned
-
2021
- 2021-10-06 JP JP2021164474A patent/JP2022003081A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN02938A (enExample) | 2015-09-18 |
| EP3329938A1 (en) | 2018-06-06 |
| EP3329938B1 (en) | 2021-06-23 |
| EP2895194A1 (en) | 2015-07-22 |
| WO2014040176A1 (en) | 2014-03-20 |
| IL237657A0 (en) | 2015-04-30 |
| KR20210072827A (ko) | 2021-06-17 |
| MX2015003361A (es) | 2015-10-22 |
| JP2022003081A (ja) | 2022-01-11 |
| AU2013315303A1 (en) | 2015-03-19 |
| AU2013315303B2 (en) | 2018-07-26 |
| CN104755101A (zh) | 2015-07-01 |
| CN104755101B (zh) | 2018-10-02 |
| KR20150068358A (ko) | 2015-06-19 |
| ZA201501700B (en) | 2016-01-27 |
| JP2015528472A (ja) | 2015-09-28 |
| HK1208807A1 (en) | 2016-03-18 |
| BR112015005382A2 (pt) | 2019-11-26 |
| MX367670B (es) | 2019-08-30 |
| EP3153177A1 (en) | 2017-04-12 |
| JP2018076343A (ja) | 2018-05-17 |
| KR20180110240A (ko) | 2018-10-08 |
| US20190133908A1 (en) | 2019-05-09 |
| EP2895194A4 (en) | 2016-03-09 |
| HK1212592A1 (zh) | 2016-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528472A5 (enExample) | ||
| RU2015113528A (ru) | Косметические композиции для биофотонной терапии | |
| KR20180027643A (ko) | 광선 요법용 양자점 발광 다이오드 | |
| JP2022003081A (ja) | 生体光組成物 | |
| RU2010126148A (ru) | Композиция для фотодинамического лечения кожи | |
| CN203970547U (zh) | 一种出射均匀光斑的半导体激光器医疗模组 | |
| CA2584970A1 (en) | Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound | |
| JP2017509433A5 (enExample) | ||
| RU2016151724A (ru) | Термоотверждаемые биофотонные композиции и их применения | |
| Bjerring et al. | Dermal collagen production following irradiation by dye laser and broadband light source | |
| CN202070020U (zh) | 一种led光动力治疗仪 | |
| KR20160032379A (ko) | 스킨캐어장치 | |
| Jalili | Chromophore gel-assisted phototherapy: A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging | |
| RU2010122692A (ru) | Способ лечения поверхностного рака мочевого пузыря | |
| CN101559257A (zh) | 一种红光活血仪 | |
| CN104147705A (zh) | 一种可产生时变光强输出的光子治疗装置 | |
| US20070231307A1 (en) | Energy assisted stem cell extract | |
| KR20060031262A (ko) | 엔디-야그 레이저 치료기와 자외선 치료기 및 아이피엘치료기로 된 3 모드 피부광학 치료장치 | |
| CA2947392C (en) | Apparatus and method for multiwavelength photodynamic therapy | |
| CN216255908U (zh) | 一种美容嫩肤美甲灯 | |
| CN204307223U (zh) | 带氧管的激光光动力治疗仪 | |
| RU2010129236A (ru) | Способ лечения местнораспространенных онкологических заболеваний в эксперименте | |
| CN206762042U (zh) | 一种美容用5050光源 | |
| WO2010026491A3 (en) | Procedure to remove pigmentary stains and tatoos on the skin by a solid-state dye laser system | |
| Edge et al. | Biophotonic Therapy Induced Photobiomodulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180718 |